ATE238805T1 - Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält - Google Patents

Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält

Info

Publication number
ATE238805T1
ATE238805T1 AT97904162T AT97904162T ATE238805T1 AT E238805 T1 ATE238805 T1 AT E238805T1 AT 97904162 T AT97904162 T AT 97904162T AT 97904162 T AT97904162 T AT 97904162T AT E238805 T1 ATE238805 T1 AT E238805T1
Authority
AT
Austria
Prior art keywords
nicotinic acid
lowering blood
blood cholesterol
acid
fat absorption
Prior art date
Application number
AT97904162T
Other languages
English (en)
Inventor
Ivan Furda
Original Assignee
Ivan Furda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivan Furda filed Critical Ivan Furda
Application granted granted Critical
Publication of ATE238805T1 publication Critical patent/ATE238805T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT97904162T 1996-02-14 1997-02-04 Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält ATE238805T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/601,388 US5736532A (en) 1996-02-14 1996-02-14 Multifunctional fat absorption and blood cholesterol reducing formulation comprising chitosan
PCT/US1997/001635 WO1997029760A1 (en) 1996-02-14 1997-02-04 Multifunctional fat absorption and blood cholesterol reducing formulation containing chitosan and nicotinic acid

Publications (1)

Publication Number Publication Date
ATE238805T1 true ATE238805T1 (de) 2003-05-15

Family

ID=24407295

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97904162T ATE238805T1 (de) 1996-02-14 1997-02-04 Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält

Country Status (10)

Country Link
US (1) US5736532A (de)
EP (1) EP0881903B1 (de)
JP (1) JP2000504724A (de)
AT (1) ATE238805T1 (de)
AU (1) AU1852597A (de)
DE (1) DE69721497T2 (de)
ES (1) ES2199342T3 (de)
ID (1) ID15895A (de)
WO (1) WO1997029760A1 (de)
ZA (1) ZA971134B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1100344E (pt) 1998-07-30 2004-09-30 Vital Living Inc Novas composicoes liquidas contendo quitosana e metodos para a sua preparacao e utilizacao
GB9920393D0 (en) * 1999-08-27 1999-11-03 Medix Scient Uk Limited Plant extract mixtures and their uses
WO2003013471A2 (en) * 2001-08-08 2003-02-20 Paolina Galvao Pharmaceutical enteric coated composition comprising chitosan
US6897348B2 (en) 2001-12-19 2005-05-24 Kimberly Clark Worldwide, Inc Bandage, methods of producing and using same
US7419655B2 (en) * 2002-09-11 2008-09-02 Kimberly-Clark Worldwide, Inc. Skin care products
GB0302741D0 (en) * 2003-02-06 2003-03-12 Advanced Biopolymers As Use
RU2232775C1 (ru) * 2003-05-16 2004-07-20 Общество с ограниченной ответственностью "Инвест-Фарм" Способ получения ионосвязанных производных олигосахарида хитозана
US20070116713A1 (en) * 2005-11-22 2007-05-24 Gill Robert P Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
KR100882611B1 (ko) * 2006-11-14 2009-02-12 주식회사 키토라이프 표적 리간드로서 폴릭산이 도입된 유전자 전달체용저분자량 수용성 키토산 나노입자 및 이의 제조방법
US7659313B2 (en) * 2007-09-13 2010-02-09 Gateway Health Alliances, Inc. Methods and related compositions using specific indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals
CN102469782A (zh) 2010-06-18 2012-05-23 哈洛资源公司 包含壳聚糖的固态共混物的制剂及方法
KR20150021071A (ko) * 2012-06-15 2015-02-27 코나리스 리써치 인스티튜트 아게 니코틴산 및/또는 니코틴아미드 및/또는 트립토판을 포함하는 장내 세균총에 유익한 효능을 가진 약학 조성물
KR20160088436A (ko) * 2013-12-13 2016-07-25 코나리스 리써치 인스티튜트 아게 니코틴아미드 및 5-아미노살리실산의 조합을 포함하는, 장내 세균총에 유익한 영향을 미치거나 및/또는 위장 염증을 치료하기 위한 약학 조성물
PT3079675T (pt) 2013-12-13 2020-03-05 Conaris Res Institute Ag Uma composição farmacêutica que contém ácido nicotínico e/ou nicotinamida para utilização para influenciar beneficamente os níveis de lípidos no sangue através da modificação da microbiota intestinal
ITUA20161937A1 (it) * 2016-03-23 2017-09-23 S I I T S R L Servizio Int Imballaggi Termosaldanti Preparazione per il controllo del peso corporeo a base di chitosano e cellulosa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223023A (en) * 1978-10-12 1980-09-16 Ivan Furda Nonabsorbable lipid binder
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
US5300494A (en) * 1986-06-06 1994-04-05 Union Carbide Chemicals & Plastics Technology Corporation Delivery systems for quaternary and related compounds
JP2667351B2 (ja) * 1992-03-24 1997-10-27 麒麟麦酒株式会社 食餌脂質消化吸収阻害剤および飲食品
US5420197A (en) * 1994-01-13 1995-05-30 Hydromer, Inc. Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives

Also Published As

Publication number Publication date
WO1997029760A1 (en) 1997-08-21
ID15895A (id) 1997-08-14
ZA971134B (en) 1997-08-25
DE69721497D1 (de) 2003-06-05
ES2199342T3 (es) 2004-02-16
AU1852597A (en) 1997-09-02
US5736532A (en) 1998-04-07
EP0881903B1 (de) 2003-05-02
JP2000504724A (ja) 2000-04-18
EP0881903A1 (de) 1998-12-09
DE69721497T2 (de) 2004-03-18

Similar Documents

Publication Publication Date Title
DE69721497D1 (de) Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält
CA2231292A1 (en) Method for decreasing ldl-cholesterol concentration and increasing hdl-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
DE69822832D1 (de) Therapeutische und lebensmittel-zusammensetzungen, welche essentielle fettsäuren und bioaktive disulfide enthalten
FR2634376B1 (fr) Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
BR9810547A (pt) Absorção de minerais pelas células intestinais
US4393049A (en) Treatment for obesity
GB9312853D0 (en) Chemical compounds
AU6340686A (en) Pharmaceutical and dietary composition
HK1042853A1 (zh) 含必需脂肪酸和高半胱氨酸降低劑的藥物和營養組合物
DE69620291D1 (de) Nahrungszusammensetzungen in verschiedenen Formen
AU5079600A (en) Composition comprising ozonized oils and/or other ozonized natural and/or synthetic products and their use in pharmaceutical, cosmetic, dietetic or food supplement compositions in human and veterinary medicine
IT8423086A1 (it) Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
WO2002064148A3 (en) Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders
GR3030525T3 (en) Nitrous oxide containing dermatological composition.
PT1216041E (pt) Dieta com elevado teor de lipidos
SG46307A1 (en) New pyrazine derivatives the preparation and use thereof
GR3035613T3 (en) Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
PH25313A (en) Carboxylic acid derivatives, pharmaceutical compositions containing them
ATE160561T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
SE9801647D0 (sv) Therapeutic composition
GB2210789A (en) Topical application for skin care
ATE275835T1 (de) Zinc und linolsäure enthaltendes nährungsmittel
FR2658190B1 (fr) Esters d'aminoacides de l'hydroquinone, leur procede de preparation et compositions pharmaceutiques ou cosmetiques les contenant.
BR9611609A (pt) Composição dietética que pode ser absorvida, capaz de melhorar equilìbrio biológico da flora do trato intestinal
AU3992897A (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties